![LGC has sold DDS to Alliance Pharma, a portfolio company of Ampersand and KKR - Lincoln International LLC LGC has sold DDS to Alliance Pharma, a portfolio company of Ampersand and KKR - Lincoln International LLC](https://cdn.lincolninternational.com/wp-content/uploads/Crisman_Anthony_616.jpg)
LGC has sold DDS to Alliance Pharma, a portfolio company of Ampersand and KKR - Lincoln International LLC
![LGC has sold DDS to Alliance Pharma, a portfolio company of Ampersand and KKR - Lincoln International LLC LGC has sold DDS to Alliance Pharma, a portfolio company of Ampersand and KKR - Lincoln International LLC](https://cdn.lincolninternational.com/wp-content/uploads/Lethbridge_Edward_616.png)
LGC has sold DDS to Alliance Pharma, a portfolio company of Ampersand and KKR - Lincoln International LLC
![Ampersand Portfolio Company U.S. Alliance Pharma Acquires U.K.-based LGC's Drug Development Solutions (DDS) Business | Ampersand Capital Ampersand Portfolio Company U.S. Alliance Pharma Acquires U.K.-based LGC's Drug Development Solutions (DDS) Business | Ampersand Capital](https://ampersandcapital.com/wp-content/uploads/2022/07/Alliance-Pharma-Acquires-LGC-DDS.jpeg)
Ampersand Portfolio Company U.S. Alliance Pharma Acquires U.K.-based LGC's Drug Development Solutions (DDS) Business | Ampersand Capital
Press release under embargo until Tuesday 17 May 12.00 BST Ampersand-backed Alliance Pharma to acquire LGC's Drug Development
![LGC has sold DDS to Alliance Pharma, a portfolio company of Ampersand and KKR - Lincoln International LLC LGC has sold DDS to Alliance Pharma, a portfolio company of Ampersand and KKR - Lincoln International LLC](https://cdn.lincolninternational.com/wp-content/uploads/LGC_Alliance-Pharma_KKR_Ampersand_2022.png)
LGC has sold DDS to Alliance Pharma, a portfolio company of Ampersand and KKR - Lincoln International LLC
Ampersand Capital Partners på LinkedIn: U.S. Alliance Pharma Expands Early Phase Bioanalytical Services Into…
Branden Berns on LinkedIn: It's official. The new year has been an excellent occasion to reflect on… | 114 comments
Ampersand-backed Alliance Pharma to acquire LGC's Drug Development Solutions Business (“DDS”) and welcomes KKR as joint sh
![Ampersand-backed Alliance Pharma to acquire LGC's Drug Development Solutions Business (“DDS”) and welcomes KKR as joint shareholder | Ampersand Capital Ampersand-backed Alliance Pharma to acquire LGC's Drug Development Solutions Business (“DDS”) and welcomes KKR as joint shareholder | Ampersand Capital](https://ampersandcapital.com/wp-content/uploads/2022/05/Ampersand-logo-Twitter-1024x512-1.jpg)